These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16921067)

  • 1. Measuring the impact of chemotherapy on fertility in women with breast cancer.
    Oktay K; Oktem O; Reh A; Vahdat L
    J Clin Oncol; 2006 Aug; 24(24):4044-6. PubMed ID: 16921067
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-Müllerian hormone: a new marker for ovarian function.
    Visser JA; de Jong FH; Laven JS; Themmen AP
    Reproduction; 2006 Jan; 131(1):1-9. PubMed ID: 16388003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.
    Fanchin R; Taieb J; Lozano DH; Ducot B; Frydman R; Bouyer J
    Hum Reprod; 2005 Apr; 20(4):923-7. PubMed ID: 15640257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
    Reh A; Oktem O; Oktay K
    Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics.
    La Marca A; Orvieto R; Giulini S; Jasonni VM; Volpe A; De Leo V
    Fertil Steril; 2004 Oct; 82(4):970-2. PubMed ID: 15482785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum anti-Müllerian hormone and inhibin B in disorders of spermatogenesis.
    Muttukrishna S; Yussoff H; Naidu M; Barua J; Arambage K; Suharjono H; Sathanandan M
    Fertil Steril; 2007 Aug; 88(2):516-8. PubMed ID: 17462637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oocyte quality and ovarian reserve].
    Hazout A
    J Gynecol Obstet Biol Reprod (Paris); 2006 Sep; 35(5 Pt 2):2S35-2S36. PubMed ID: 17057620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of breast cancer treatment on fertility.
    de la Haba-Rodríguez J; Calderay M
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():59-63. PubMed ID: 20711656
    [No Abstract]   [Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.
    Badawy A; Elnashar A; El-Ashry M; Shahat M
    Fertil Steril; 2009 Mar; 91(3):694-7. PubMed ID: 18675959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian function and childbearing issues in breast cancer survivors.
    Gadducci A; Cosio S; Genazzani AR
    Gynecol Endocrinol; 2007 Nov; 23(11):625-31. PubMed ID: 17926162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH analogue for chemotherapy-induced ovarian damage: too early to say?
    Peccatori F; Demeestere I
    Fertil Steril; 2009 Aug; 92(2):e33; author reply e34. PubMed ID: 19646600
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].
    Li HP; Ma LW; Zhang SL; Jia TZ; Deng HJ; Zhang ZH; Liang L; Wang MP; Xiao Y; Cao BS; Chen S; Wang YF
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):848-51. PubMed ID: 17416008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
    McIlveen M; Skull JD; Ledger WL
    Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone and folliculogenesis.
    Visser JA; Themmen AP
    Mol Cell Endocrinol; 2005 Apr; 234(1-2):81-6. PubMed ID: 15836956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker.
    Themmen AP
    J Natl Cancer Inst Monogr; 2005; (34):18-21. PubMed ID: 15784815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy.
    Hehenkamp WJ; Volkers NA; Broekmans FJ; de Jong FH; Themmen AP; Birnie E; Reekers JA; Ankum WM
    Hum Reprod; 2007 Jul; 22(7):1996-2005. PubMed ID: 17582145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women.
    Kevenaar ME; Themmen AP; Laven JS; Sonntag B; Fong SL; Uitterlinden AG; de Jong FH; Pols HA; Simoni M; Visser JA
    Hum Reprod; 2007 Jun; 22(6):1547-54. PubMed ID: 17337470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum müllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization.
    Nakhuda GS; Chu MC; Wang JG; Sauer MV; Lobo RA
    Fertil Steril; 2006 May; 85(5):1541-3. PubMed ID: 16566934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of recovery of ovarian function during weight gain in anorexia nervosa.
    van Elburg AA; Eijkemans MJ; Kas MJ; Themmen AP; de Jong FH; van Engeland H; Fauser BC
    Fertil Steril; 2007 Apr; 87(4):902-8. PubMed ID: 17239876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate.
    Mohamed KA; Davies WA; Lashen H
    Fertil Steril; 2006 Nov; 86(5):1515-7. PubMed ID: 16978621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.